Adverum Biotechnologies (ADVM)
(Real Time Quote from BATS)
$7.51 USD
-0.09 (-1.18%)
Updated May 28, 2024 11:11 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Earnings News For ADVM
-
Adverum Biotechnologies: Q1 Earnings Snapshot
-
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
-
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
-
Adverum Biotechnologies: Q3 Earnings Snapshot
-
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
-
Adverum Biotechnologies: Q2 Earnings Snapshot
-
Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results
-
Adverum Biotechnologies: Q1 Earnings Snapshot
-
Adverum Biotechnologies Reports First Quarter 2023 Financial Results
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies: Q4 Earnings Snapshot
-
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
-
Adverum Biotechnologies: Q3 Earnings Snapshot
-
Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
-
Adverum Biotechnologies: Q2 Earnings Snapshot
-
Adverum Biotechnologies Reports Second Quarter 2022 Financial Results
-
Adverum Biotechnologies (ADVM) Reports Q1 Loss, Tops Revenue Estimates
-
Adverum Biotechnologies (ADVM) Reports Q4 Loss, Misses Revenue Estimates
-
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Misses Revenue Estimates
-
Analysts Estimate Adverum Biotechnologies (ADVM) to Report a Decline in Earnings: What to Look Out for
-
Adverum Biotechnologies (ADVM) Reports Q2 Loss, Lags Revenue Estimates
-
Adverum Biotechnologies (ADVM) Reports Q1 Loss, Lags Revenue Estimates